Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
60.52
+2.28 (3.91%)
At close: Jan 21, 2025, 4:00 PM
58.17
-2.35 (-3.88%)
After-hours: Jan 21, 2025, 4:05 PM EST
Disc Medicine Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
74
Market Cap
1.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIRON News
- 7 hours ago - Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 15 hours ago - Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission - GlobeNewsWire
- 1 day ago - Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) - GlobeNewsWire
- 4 days ago - Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 6 weeks ago - Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 2 months ago - Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc. - GlobeNewsWire